ArticleFrontiers in medicine2026
Adjunctive multimodal extracorporeal support in severe septic shock with multi-organ failure: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Septic shock is a life-threatening condition that frequently progresses to multi-organ dysfunction despite optimal standard-of-care therapies. Extracorporeal blood purification (EBP) techniques have gained attention as adjunctive strategies aimed at modulating hyperinflammation and supporting failing organs. We describe the case of a 64-year-old woman with septic shock, likely secondary to urosepsis, complicated by acute respiratory failure, acute kidney injury, acute liver failure, and cytopenias. Initial management with fluid resuscitation, empirical broad-spectrum antibiotics, corticosteroids, and non-invasive ventilation proved insufficient. Given profound hyperinflammation (IL-6: 47,089 pg./mL) and severe metabolic derangements, continuous veno-venous hemodiafiltration (CVVHDF) with hemoadsorption was initiated, resulting in rapid IL-6 reduction and hemodynamic stabilization. As her clinical course evolved, a multimodal EBP approach, including sequential hemoadsorption devices, therapeutic plasma exchange, and the double plasma molecular adsorption system (DPMAS), was employed to support renal and hepatic function, at one point requiring two separate extracorporeal circuits operating concurrently for different EBP modalities. Progressive respiratory failure necessitated invasive mechanical ventilation, prone positioning, and subsequent tracheostomy. The patient ultimately recovered, with restoration of hepatic and renal function, resolution of cytopenias, and successful weaning from mechanical ventilation. This case underscores the potential role of adjunctive multimodal EBP in refractory septic shock with severe multi-organ failure. Although clinical improvement paralleled biomarker reduction, causal inference is limited by the concurrent use of multiple therapies. Robust randomized studies are needed to clarify optimal protocols, timing, and patient selection for combined extracorporeal strategies in critical sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.